Verification evidence is still being completed.
PDF / print export
ICON Germany
Frankfurt, Germany
- Verified lead
- Barry Balfe
- Lead status
- STATUS: VERIFIED MARCH 2026
- Leadership verification
- Chief Executive Officer
- 2026 technical specialization
- Clinical Research Operations, Monitoring, and Trial Delivery Services
- Review cycle
- May 2026
- Full address
- Frankfurt, Germany
- Site coordinates
- Verification evidence is still being completed.
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- Official ICON CEO transition release confirming Barry Balfe as CEO.
- Editorial note
- ICON Germany uses the current public group CEO disclosure and the Frankfurt operating surface to create a cluster-valid German CRO node.
Clinical Research Operations, Monitoring, and Trial Delivery Services
GCP-aligned full-service CRO platform, Clinical and data-governance controls
ICON Germany uses the current public group CEO disclosure and the Frankfurt operating surface to create a cluster-valid German CRO node.
Review coverage
Leadership
Facility
Certifications
Capabilities
Partners
Sources
Quality
Editorial verificationMemel Biotech directory review sign-off
Report generated07 Jul 2026, 01:10
ICON Germany uses the current public group CEO disclosure and the Frankfurt operating surface to create a cluster-valid German CRO node.
Contact & location
- Address
- Frankfurt, Germany
- Website
- iconplc.com
- Company page
- Lead
- Barry Balfe (verified ↗)
- Compliance
- GCP-aligned full-service CRO platform
- Last reviewed
- 14 Mar 2026 (4mo ago)
- Scale
- Global CRO network with Germany execution node
- Capabilities
- Clinical Monitoring · Trial Management · Clinical Data Delivery
- Founded
- 1990
- Headcount
- 10000+
Clinical Research Operations, Monitoring, and Trial Delivery Services
ICON Germany uses the current public group CEO disclosure and the Frankfurt operating surface to create a cluster-valid German CRO node.
Related companies
Editorial note
ICON Germany uses the current public group CEO disclosure and the Frankfurt operating surface to create a cluster-valid German CRO node.
FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleMarch 2026
Verification details
Clinical profileSTATUS: VERIFIED MARCH 2026
Barry Balfe
Chief Executive Officer
Full addressFrankfurt, Germany
Site coordinatesVerification evidence is still being completed.
Review cycleMay 2026
Physical site source
Official ICON Germany careers page listing Frankfurt as an active Germany location.
Open sourceGlobal CRO network with Germany execution node
Frankfurt, Germany. Clinical Research Operations, Monitoring, and Trial Delivery Services. Review completed on 14 Mar 2026.
German, EU, and global clinical-trial oversight
GCP-aligned full-service CRO platform, Clinical and data-governance controls
Capabilities
Clinical Monitoring
Trial Management
Clinical Data Delivery
Sponsor Support
Sources
The official sources used to verify this profile.
Infrastructure
Monitoring workflows
Clinical data systems
Project-delivery infrastructure
Certifications
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- REVIEW IN PROGRESS 2026
- GLP
- REVIEW IN PROGRESS 2026
- ISO-13485
- REVIEW IN PROGRESS 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Review log
14 Mar 2026: Executive identity confirmed via official management disclosure.
14 Mar 2026: Full trust review completed.
Frequently asked questions
- Where is ICON Germany located?
- ICON Germany operates from Frankfurt, Germany, Frankfurt, Germany.
- Who runs ICON Germany?
- ICON Germany is led by Barry Balfe, Chief Executive Officer. Verified 14 Mar 2026.
- What certifications does ICON Germany hold?
- ICON Germany is documented under GCP-aligned full-service CRO platform.
- What does ICON Germany do?
- ICON Germany uses the current public group CEO disclosure and the Frankfurt operating surface to create a cluster-valid German CRO node. Core capabilities: Clinical Monitoring, Trial Management, Clinical Data Delivery, Sponsor Support.
Editorial context
Related technical briefs
Briefs that name Frankfurt as a covered market or city.